SMF-1, SMF-2 and SMF-3 DMT1 orthologues regulate and are regulated differentially by manganese levels in C. elegans by Au, Catherine et al.
HAL Id: hal-00439893
https://hal.archives-ouvertes.fr/hal-00439893
Submitted on 4 Oct 2018
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Distributed under a Creative Commons Attribution| 4.0 International License
SMF-1, SMF-2 and SMF-3 DMT1 orthologues regulate
and are regulated differentially by manganese levels in
C. elegans
Catherine Au, Alexandre Benedetto, Joel Anderson, Arnaud Labrousse, Keith
Erikson, Jonathan J Ewbank, Michael Aschner
To cite this version:
Catherine Au, Alexandre Benedetto, Joel Anderson, Arnaud Labrousse, Keith Erikson, et al.. SMF-1,
SMF-2 and SMF-3 DMT1 orthologues regulate and are regulated differentially by manganese lev-
els in C. elegans. PLoS ONE, Public Library of Science, 2009, 4 (11), pp.e7792. ￿10.1371/jour-
nal.pone.0007792￿. ￿hal-00439893￿
SMF-1, SMF-2 and SMF-3 DMT1 Orthologues Regulate
and Are Regulated Differentially by Manganese Levels in
C. elegans
Catherine Au1,2., Alexandre Benedetto1,3,8., Joel Anderson4", Arnaud Labrousse5,6,7,9", Keith Erikson4,
Jonathan J. Ewbank5,6,7, Michael Aschner1,2,3*
1Department of Pediatrics, Vanderbilt University, Nashville, Tennessee, United States of America, 2Center for Molecular Toxicology, Vanderbilt University, Nashville,
Tennessee, United States of America, 3Children’s Hospital, Vanderbilt University, Nashville, Tennessee, United States of America, 4Department of Nutrition, The University
of North Carolina Greensboro, Greensboro, North Carolina, United States of America, 5Centre d’Immunologie de Marseille-Luminy, Universite´ de la Me´diterrane´e,
Marseille, France, 6U631, INSERM, Marseille, France, 7UMR6102, CNRS, Marseille, France, 8 London Centre for Nanotechnology, University College London, London,
United Kingdom, 9 Institut de Pharmacologie et de Biologie Structurale, Universite´ Paul Sabatier Toulouse III, Toulouse, France
Abstract
Manganese (Mn) is an essential metal that can exert toxic effects at high concentrations, eventually leading to Parkinsonism. A
major transporter of Mn in mammals is the divalent-metal transporter (DMT1). We characterize here DMT1-like proteins in the
nematode C. elegans, which regulate and are regulated by Mn and iron (Fe) content. We identified three new DMT1-like genes
in C. elegans: smf-1, smf-2 and smf-3. All three can functionally substitute for loss of their yeast orthologues in S. cerevisiae. In the
worm, deletion of smf-1 or smf-3 led to an increased Mn tolerance, while loss of smf-2 led to increased Mn sensitivity. smfmRNA
levels measured by QRT-PCR were up-regulated upon lowMn and down-regulated upon highMn exposures. Translational GFP-
fusions revealed that SMF-1 and SMF-3 strongly localize to partially overlapping apical regions of the gut epithelium, suggesting
a differential role for SMF-1 and SMF-3 in Mn nutritional intake. Conversely, SMF-2 was detected in the marginal pharyngeal
epithelium, possibly involved in metal-sensing. Analysis of metal content upon Mn exposure in smfmutants revealed that SMF-
3 is required for normal Mn uptake, while smf-1 was dispensable. Higher smf-2 mRNA levels correlated with higher Fe content,
supporting a role for SMF-2 in Fe uptake. In smf-1 and smf-3 but not in smf-2 mutants, increased Mn exposure led to decreased
Fe levels, suggesting that both metals compete for transport by SMF-2. Finally, SMF-3 was post-translationally and reversibly
down-regulated following Mn-exposure. In sum, we unraveled a complex interplay of transcriptional and post-translational
regulations of 3 DMT1-like transporters in two adjacent tissues, which regulate metal-content in C. elegans.
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Introduction
Manganese (Mn) is one of the most abundant natural elements
in the Earth’s crust. It most frequently occurs in the form of oxides,
carbonates and silicates [1]. It is one of 7 essential metals for
animals, acting as a cofactor for multiple proteins with a wide
variety of biological activities, such as transferases, hydrolases,
lyases, arginase, glutamine synthetase, superoxide dismutase and
integrins [2,3]. Consequently, Mn is essential for many physio-
logical processes, such as modulation of the immune system,
stellate process production in astrocytes, as well as protein, lipid
and carbohydrate metabolism [4,5,6,7,8]. Mn is also essential for
optimal brain and skeletal structure development [9,10]; Mn
deficiency has been associated with defective bone formation and
increased susceptibility to seizures [11,12]. Despite being essential
for metabolic functions, Mn at high concentrations can be toxic,
especially to the brain. Though most Mn is obtained through the
diet, Mn toxicity from dietary intake is rare, because Mn balance is
tightly regulated by both the enterocytes (intake) and the biliary
duct cells (excretion). In contrast, pulmonary uptake and
particulate transport via the olfactory bulb [2,13,14] can lead to
deposition of Mn within the striatum and cerebellum, and
inflammation of the nasal epithelium [15]. Exposure to excessive
Mn levels may cause an extrapyramidal syndrome, referred to as
manganism, closely resembling idiopathic Parkinson’s disease
(IPD), both at the molecular and clinical level [16,17,18]. Mn
exposure represents a significant public health matter due to the
use of Mn as a catalyser in countless industrial processes, its
presence in gasoline additive, fungicides such as Maneb and in
permanganate, a drinking water purifier [1,2,19,20,21]. Because
Mn is the only environmental toxicant that has been robustly
associated with IPD, studies on the mechanisms that mediate its
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toxicity offer means for better understanding of neurodegenerative
diseases, the frequency of which is on the rise [22,23,24].
Due to the delicate relationship between essentiality and toxicity,
Mn homeostasis is crucial for all eukaryotes. Previous research has
focused onMn transport mechanisms across the blood-brain barrier
(BBB), but the nature and relative contributions of the carrier(s)
identified thus far remain controversial. Over the past two decades,
active transport [25] and facilitated diffusion [26,27] mechanisms
have been described. More recently, Mn transport has been
ascribed to high affinity metal transporters of calcium (Ca) and iron
(Fe). Amongst these, attention has been directed to the divalent
metal transporter (DMT1 [28]), which belongs to the family of
natural resistance-associated macrophage protein (NRAMP)
[29,30,31,32]. To avoid confusion, we will further refer to NRAMP
family members as DMT(s) for Divalent Metal Transporter(s).
DMT1, previously known as NRAMP2, was first identified as
an orthologue of NRAMP1, a protein involved in host defense
against several types of infection [29,30]. Subsequently, it was
referred to as divalent cation transporter (DCT1), because of its
ability to transport divalent zinc (Zn2+), manganese (Mn2+), cobalt
(Co2+), cadmium (Cd2+), copper (Cu2+), nickel (Ni2+), lead (Pb2+),
and iron (Fe2+) [32,33,34]. In 1999 it was designated as DMT1
[28]. DMT1 is an integral membrane protein conserved from
bacteria to humans, containing 11 to 12 transmembrane domains
(TMD) and a ‘‘consensus transport sequence’’ (CTS) involved in
divalent metal ion transport [32,33,34,35]. Notably, rodent models
presenting a spontaneous mutation in DMT1, microcytic (mk)
mice and Belgrade (b/b) rats [36], and several human mutations in
DMT1 [37,38,39,40,41,42] suggest an association between
microcytic anemia, impairment of Fe transport and Mn
homeostasis. In vertebrates, DMT1 is ubiquitously expressed,
but more abundant expression is observed in the proximal
duodenum compared to the kidney or the brain [28,32,43].
Within the brain, the basal ganglia express higher levels of DMT1,
where Mn preferentially accumulates [44]. At a subcellular level,
DMT1 is strongly localized at the apical membrane in enterocytes
[45] and sustentacular cells of the olfactory epithelium [14]
whereas in macrophages, it is restricted to the phagosomal
membrane. The vertebrate DMT1 gene produces four alterna-
tively spliced mRNAs differing by the presence or absence of the
exon 0, and a 39 sequence in which an iron regulatory element is
present or absent (+IRE and -IRE respectively). The 39 UTR is
responsible for the modulation of the +IRE mRNA stability by the
intracellular Fe pool [32]. The +IRE vs -IRE mRNAs encode
DMT1 isoforms with distinct carboxy- termini [43,46]. The +IRE
isoforms are found mainly at the apical membrane of epithelial
cells [45,47] and in late endosomes and lysosomes within HEp-2
cells [40,48]. The -IRE isoforms are found predominantly in early
and recycling endosomes [49,50,51]. Studies in yeast have
identified three DMT1 orthologues: Smf1p, Smf2p and Smf3p,
encoded by SMF1, SMF2 and SMF3 respectively. In contrast to
vertebrate DMT1, no typical IRE is found in any of the SMF
genes, and the poor sequence conservation of the C-termini is not
predictive of a correspondence between the vertebrate –IRE/
+IRE isoforms and Smf1p/2p/3p. However, Smf1p was identified
as a non-specific metal ion transporter for Mn2+, Zn2+, Cu2+, Fe2+
and Cd2+ [52,53] and Smf2p was also found to be involved in Mn
transport [54]. Analogous to their vertebrate orthologues, the yeast
DMTs are found in various intracellular compartments: Smf1p at
the cell surface, Smf2p in vesicles and Smf3p exclusively at the
vacuolar membrane [53,55,56]. In addition, they differentially
contribute to Mn homeostasis, since Smfp1 and Smf3p are
dispensable in Mn-replete conditions [53], while Smf2p is essential
for ensuring proper Mn uptake [57,58]. Additionally, the SMF3
promoter is found to contain a target sequence for the Fe-sensing
transcription factor Aft1p, which is responsible for its transcrip-
tional regulation by Fe, whereas Smf1p and Smf2p levels are
unaffected by Fe concentration [55,56].
Currently, both Mn transport and DMT protein function(s) are
poorly understood. This is partly due to the existence of several
DMT proteins differentially regulated at the transcriptional and
post-translational levels, in distinct tissues (intestine, liver, kidney,
brain) and under various conditions (Mn or Fe levels, infection).
Moreover, findings in a unicellular organism like the baker’s yeast
are difficult to translate to metazoans and especially to mammals.
Given the current lack of a genetically amenable animal model, we
used the C. elegans system to address these issues. We identified and
cloned three functional C. elegansDMT1 orthologues SMF-1, SMF-2
and SMF-3, with distinct roles in Mn transport regulation. Our
results support an evolutionary conserved function for DMT1
isoforms in the regulation of Mn uptake, and emphasize the
differential contribution and regulation of DMT1 isoforms expressed
in different tissues and exhibiting different subcellular localizations.
Furthermore, our study identifies SMF-3 as the main Mn uptake
transporter in the worm, whereas SMF-1 has a minor role in this
process and SMF-2 is involved in metal content regulation.
Methods
Multiple alignment generation and analysis. - Protein sequences were
uploaded from the NCBI website (http://www.ncbi.nlm.nih.gov/
sites/entrez). Multiple alignments and phylogenetic trees were
generated using ClustalX1.81 [59] running ClustalW [60].
Yeast handling, transformation and EGTA sensitivity assessment. - Yeast
strains, maintenance, transformation and culture for the EGTA
sensitivity assay were performed as described [58]. Plasmids pVT-
Cesmf-1, pVT-Cesmf-2 and pVT-Cesmf-3, for yeast expression of
C. elegans genes smf-1, smf-2 and smf-3 respectively, were generated as
follows. smf-1 (from yk452d4) and smf-3 (from yk397h3) cDNA were
kindly provided by Yuji Kohara, while smf-2 cDNAwas obtained by
reverse-transcription-PCR. smf-1 was amplified using primers 59-
CAG CGG ATC CGC TTG ATA TCC TGC ATT GTC-39 and
59-GAC CGG TAC CGG AAA GTA TAC ATC GTT CAC-39.
smf-3 was amplified using primers 59-CGCGGATCCAATGG-
AGGTGAAATGAAAT-39 and 59-GCCCGGTACCGCATA-
TCGCATAGACAGTTC-39. smf-1’ smf-2, and smf-3 fragments
were then cloned into pVT101-U using HindIII and PstI.
C. elegans strains and handling of the worms. - C. elegans strains were
handled and maintained at 20uC as previously described [61]. The
following strains were used: N2 (wildtype); IG6, smf-1(eh5) X;
VC171, smf-2(gk133) X; RB1074, smf-3(ok1035) IV; MT455, lon-
2(e678) unc-18(e81) X; MT628, dpy-9(e12) unc-17(e245) IV. All
strains were provided by the Caenorhabditis Genetic Center
(CGC, Minnesota). The IG6, VC171 and RB1074 strains were
outcrossed 4 additional times to generate MAB23, MAB21 and
MAB37, respectively.
Gene cloning and plasmid constructions. - Restriction enzymes were
ordered from New England Biolabs. PCR amplifications used the
LA TaqTM Polymerase (Takara), and were performed on an
Eppendorf2 PCR-machine. Translational C-terminal GFP-fusions
for SMF-1, SMF-2 and SMF-3 localization were generated as
follow. The smf-1 ORF and preceding intergenic region (4.4 kb)
was amplified using primers: 59- TAT TAC CTG CAG GAG
CTA GCT TCA TGT TCA CCG CCA AGC TCG-39, and 59-
TAT TAG GAT CCA ATT GAT ATC CTG CAT TGT CAT
GGA CTGC-39. This fragment was cloned into the pPD95.75
vector (Fire kit) between the SbfI and BamHI restriction sites, in
frame with the GFP (plasmid pMA0015). The smf-2 ORF with its
NRAMP and Mn in C. elegans
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preceding intergenic sequence (3.5 kb) was amplified using
primers: 59-TAT TCT GCA GTC ATA CGA AAA CGA TGC
TCC GTG-39 and 59-TAT TGG TAC CAC AAA GTA TAC
ATC GTT CAC AAC-39. The smf-3 ORF and its preceding
intergenic region (8.4 kb) were amplified using primers: 59-TAT
TCT GCA GAC TTC ATT GGG GAT GTG CTT TGG-39
and 59-GGT ACC CAA TAT CGC ATA GAC AGT TCG
TCG-39. The smf-2 and smf-3 amplification products were then
cloned into pPD95.75 between the PstI and KpnI restriction sites,
in frame with the GFP (plasmid pMA0010 and pMA0004
respectively). Transcriptional constructs for smf-1, smf-2 and smf-3
were obtained by cloning the preceding intergenic region,
respectively up to the 2nd, 6th and 7th exon to include highly
conserved intronic sequences. The following primer sets were
used: 59-CGC AAG CTT CGA GCA GCT CCG ATT G-39 and
59-CGC CTG CAG CCT TGT GCG CCA GAC TGA AGG-39
for smf-1, 59-TAT TGC ATG CTC ATA CGA AAA CGA TGC
TCC GTG-39 and 59-TAT TCT GCA GTA GTC CAA ACT
GAC ATC CCA GG-39 for smf-2, 59-TAT TCT GCA GAC TTC
ATT GGG GAT GTG CTT TGG-39 and 59-TAT TGT CGA
CGG CTC TGG AAT ATA ATT AGG ATT GC-39 for smf-3.
The smf-1 product (1.7 kb) was cloned between the HindIII and
PstI restriction sites in pPD95.75 (promSmf1GFP1). The smf-2
(2.6 kb) fragment was cloned into pPD95.69 (Fire kit) between the
SphI and PstI restriction sites (pMA0009). The smf-3 (5.5 kb)
fragment was cloned into pPD95.69 between the restriction sites
PstI and SalI (pMA0003).
C. elegans transgenesis. - DNA was injected into the syncytial
gonads of N2 hermaphrodites using injection mixes containing
25 ng/ml construct and 175 ng/ml pRF4 as a transformation
marker [62]. A minimum of three independent transgenic strains
per construct showing the same expression pattern were observed.
One strain for each construct was selected for this study: MAB111,
mjaEx074[SMF-1::GFP; rol-6(su1006)]; MAB120, mjaEx083[SMF-
2::GFP; rol-6(su1006)]; MAB105, mjaEx068[SMF-3::GFP; rol-
6(su1006)].
Acute manganese chloride treatments. - Manganese chloride (MnCl2)
solutions were prepared in 85 mM NaCl. For each tested strain,
5000 synchronized L1 worms per tube were exposed to 0 to 4 M of
MnCl2 in siliconized tubes for 30 minutes. Each condition was
performed in tetraplicates. Worms were then pelleted by
centrifugation at 7000 rpm for 3 minutes and washed 5 times in
85 mM NaCl. Worms from each of the siliconized tubes were then
transferred into individual 100 mm OP50-1 coated NGM plates,
which were then blinded. At 24 h post-treatment, for each plate,
live worms were scored in 4 random 1 cm2 grids to estimate the
total number of surviving worms (up to 800 counts per plate).
Scores were normalized to percent control (0 mM MnCl2
exposure).
Mn and Fe content measurement by atomic absorption spectrophotometry
(AAS). - Triplicates of 7000 L1 worms per condition were treated
with MnCl2 as previously described. The samples were washed 8
times in 85 mM NaCl. The samples were dehydrated in a vacuum
oven at 65uC for 2 hours, and further digested in 200 ml ultrapure
nitric acid for 24 hours in a sand-bath (60uC). A 20 ml aliquot of
the digested sample was brought to 1 ml total volume with 2%
nitric acid and analyzed for Mn and Fe content using graphite
furnace atomic absorption spectroscopy (AAS) (Varian AA240,
Varian, Inc USA). Bovine liver digested in ultrapure nitric acid
was used as an internal standard for analysis (NBS Standard
Reference Material, USDC, Washington, DC, diluted at 5 mg
Mn/L and 92 mg Fe/L).
Epifluorescence, DIC and confocal microscopy. - For each slide, at least
30 worms were mounted on 4% agarose pads in M9, and
anaesthetized with 0.2% tricaine/0.02% tetramisole in M9.
Fluorescence observations and DIC imaging were performed with
an epifluorescence microscope (Nikon Eclipse 80i, Nikon)
equipped with a Lambda LS Xenon lamp (Sutter Instrument
Company) and Nikon Plan Fluor 20x dry and Nikon Plan Apo 60x
1.3 oil objectives. The microscope was coupled to a black-and-
white camera (DS-Qi1Mc; Nikon) operated by the Nikon
Elements AR3.0 software (NES AR3.0) for image acquisitions.
Confocal images acquired for illustration or GFP intensity
measurement purposes were captured through Plan-Neofluar
406, Plan-Apochromat 63x, or Plan-Neofluar 1006oil objectives
with a 1.3, 1.4 and 1.3 apertures, respectively, on a LSM510
confocal microscope (Carl Zeiss MicroImaging, Inc.), scanning
every 200 nm for XZ sections. Images were processed with the
Zeiss LSM Image Browser 4.0.0.157 software and edited using
Photoshop 7.0 (Adobe). Microscopes were in air-conditioned
rooms (20–22uC).
Phenotypic characterization of Mn treated worms.- Following Mn
treatment up to 24 h post-treatment, worms were observed under
stereomicroscope (Zeiss), and mounted for microscopy phenotypic
analysis using our Nikon platform aforementioned. After 24 h at
20uC, at least 30 random control worms and 30 treated worms
exposed to 35 mM MnCl2, were imaged at 20x. We assessed their
developmental stage (L1 or L2) and their size using NES AR3.0.
SMF-3::GFP fluorescence measurements. - SMF-3::GFP transgenic
worms (MAB105) were acutely treated as described previously,
transferred on OP50-1 seeded NGM plates and imaged at 1 h, 5 h
and 30 h post-treatment. Fluorescence measurements of SMF-
3::GFP signal were performed on complete confocal Z-stack
projections of C. elegans gut. 5 to 12 animals of the same age were
imaged for each condition. Treated and untreated animals were
mounted on the same slide, and imaged with the same
magnification, gain, offset, pinhole and laser power settings. Due
to the very small signal/noise ratio for treated animals at 5 h, those
settings allowed up to 30% signal saturation for some of the 5 h,
30 h control worms and 30 h recovering worms, so that
fluorescence measurements for these conditions are underesti-
mates. Mean signal intensity of the maximal projection of the
apical membrane of the intestine (from the pharyngeal-intestinal
valve to the rectum) was measured using the freeware ImageJ.
Statistics. - Dose-response lethality curves and histograms for
Mn content measurements were generated using GraphPad Prism
(GraphPad Software Inc.). We used a sigmoidal dose-response
model with a top constraint at 100% to draw the curves and
determine the LD50 values. Statistical analysis of significance was
carried out by one-way ANOVA for the dose-response curves, and
two-way ANOVA for Mn content measurements followed by post-
hoc Bonferroni test when the overall p value was less than 0.05.
For Fe content, Fisher test revealing differences in variances
between the groups, two-tailed unpaired T-test with Welch’s
correction were used to assess differences in Fe content. In all
figures, error bars represent SEM, * p,0.05, ** p,0.01,
*** p,0.001.
RNA isolation, cDNA preparation and Real-time PCR. - 10000 N2,
MAB21, MAB23 and MAB37 synchronized L1 worms per tube
were acutely treated with MnCl2 concentrations of 0, 0.1, 10 and
100 mM, washed in NaCl 85 mM, pelleted and frozen in liquid
nitrogen. They were thawed on ice, frozen again in N2liq and
resuspended in 100 mL H2O and 350 mL Trizol (Invitrogen Life
Technologies) for RNA isolation. RNA extracts were purified using
Qiagene RNeasy mini-kit (Qiagen). Messenger RNAs were reverse-
transcribed with oligo-dT primers using the Superscript III RNAseH
Reverse transcription kit (Invitrogen). cDNAs were stored at220uC.
Quantitative Real-time-PCR was carried on a ABISystems HT7900,
NRAMP and Mn in C. elegans
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using Brilliant SYBR Green I kit (Stratagene/Agilent Technologies
Inc.), and HPLC purified primers (Operon) at a final concentration
of 120 nM. For amplification of smf-1 cDNA, two sets of 22b primers
were designed over the last intron 59-GCT CCG ATC ACC TTT
GCA TACG-39/59-ATC CTCGGA TGG AAA CGGTGTC-39,
and between exons 6 and 8 59-TTT CGC ACA TGG ACT TTA
CCA G-39/59- GCA ATA GCT CCA AAC TGG CAT C-39. For
smf-2, primers over intron 6 59-TAT TCG CAG CAG GAC AAT
CAT C-39/59-TTG TGC ATA ATC CGC TTA CTG G-39, and
over intron 10 59-GTT GCT TGCGAA CTTATG AACG-39/59-
ACA AAG GTT TCT GTG ATC CAC G-39, were used. Smf-3
cDNA was amplified using primer sets 59-TCC AGT GCT GAC
ATT TGT ATC G-39/59-CAA GGA AAT CAC AAT GGA GAC
C-39 over intron 10 and 59-GGT CTC CAT TGT GATT TCC
TTG-39/59-CGA AAT CGT GGT AGA TGG GCT CC-39 over
intron 11. cdc-42 (primers: 59-CTG CTG GAC AGG AAG ATT
ACG-39/59-CTC GGA CAT TCT CGA ATG AAG-39) and
Y45F10D4F.3 (primers: 59-GTCGCTTCAAATCAGTTCAGC-
39/59-GTT CTT GTC AAG TGA TCC GAC A-39), were used as
controls to normalize smf expression levels as they were proven to
have stable expression levels independent of age or stress conditions
[63]. The amplification setup included 109 denaturation at 95uC, 20
cycles at 95uC for 300/58uC for 19/70uC for 19, 20 to 25 cycles at
95uC for 300/56uC for 450/72uC for 450, and a dissociation curve to
ascertain that the signal did not result from primer annealing.
Results
The C. elegans genome encodes 3 DMT1 orthologues: SMF-1, SMF-2,
and SMF-3. A search on the C. elegans genome using the human
DMT1 protein sequence revealed three loci encoding DMT1
orthologues: Y69A2AR.4/smf-3 on chromosome IV, and
K11G12.3/smf-2 and K11G12.4/smf-1 on X chromosome. All
three genes encode proteins with a high degree of conservation
(Figure 1). Phylogenetic analysis placed them closer to their insects
and vertebrates orthologues than plant and yeast divalent-metal
transporters (Fig. 1A). A multiple alignment of the C. elegans SMF-
1, SMF-2, SMF-3 with their insect, vertebrates and yeast
orthologues confirmed this analysis. All three C. elegans SMF
exhibit a consensus transport sequence (CTS) quasi-identical to
their vertebrate orthologues and 12 transmembrane domains
(TMD), unlike the yeast SMF, in which the 11th TMD is absent
and the CTS is conserved at 70% (Fig. 1B).
SMF-1, SMF-2 and SMF-3 rescue the sensitivity to EGTA of the yeast
DSMF1+2 mutant. In the yeast S. cerevisiae, Smf1p and Smf2p are
divalent-metal transporters that can function in Mn uptake.
Double mutants for DSMF1+2 are hypersensitive to the divalent-
metal ion scavenger ethylene glycol tetra-acetic acid (EGTA). To
assay the molecular function of C. elegans SMF-1, -2 and -3 proteins
as divalent-metal transporters, we transvected the cDNA encoding
each of the C. elegans proteins into the DSMF1+2 yeast mutant, and
tested these transgenic strains for hypersensitivity to EGTA. All
three C. elegans SMF were able to rescue the hypersensitivity to
EGTA of the DSMF1+2 mutants (Fig. 2). Moreover, the efficacy of
the rescue was at least equivalent to the rescue conferred by
transvection of the mouse NRAMP2 cDNA construct [58].
Noticeably, the most potent effect was obtained with smf-1 cDNA,
which led to a hyper-resistant phenotype to EGTA. These results
indicate that C. elegans SMF-1, SMF-2 and SMF-3 are functionally
similar to their yeast and mammal orthologues and are likely
involved in divalent-metal ion transport.
Mn exposure can induce lethal osmoregulation defects and a developmental
delay in wild type worms. Acute exposure (30 minutes) of wild-type C.
elegans to Mn was lethal at concentrations greater than 10 mM.
Shortly after treatment and dependent upon the exposure level, a
fraction of the worms displayed vacuoles in the main epithelia:
epidermis, excretory cell and gut, tissues whose integrity is essential
for worm survival (Fig. 3). Loss of the excretory cell was the likely
cause of death, since dying worms exhibited the characteristic rod-
like phenotype (Fig. 3F&G) inherent to excretory-cell defective
mutants [64] and excretory-cell ablated worms [65]. Surviving
worms at 24 h were about 70% shorter (Fig. 3H) and displayed an
obvious developmental delay when compared with control
animals. Twenty-four hours post-treatment 83% of survivors
exposed to a 35 mM 30 min Mn treatment were still at the L1
stage, compared to 13% in the control group (Fig. 3I). The lethal
concentration 50% (LD50 at which half the worms are dead
24 hours after treatment) was 47 mM for the wild-type Bristol N2
strain (Fig. 4).
The deletion-mutants smf-1(eh5) and smf-3(ok1035) are hyper-resistant
to Mn exposure. In rodents, Mn taken up by ingestion or inhalation is
transported across the epithelial membrane via DMT1 [66]. If
DMT1 orthologues are responsible for Mn uptake in C. elegans, the
loss of function or down-regulation of these transporters should
reduce Mn sensitivity. To determine if smf-1, smf-2 and smf-3 are
involved in Mn uptake and toxicity in the worm, we made use of
available deletion-mutants for each of the three genes. Mutant smf-
1(eh5), smf-2(gk133) and smf-3(ok1035) strains were obtained from
the Caenorhabditis Genetic Center (CGC). Under standard
culture conditions, none of them displayed any obvious abnormal
phenotype with respect to body morphology, development,
growth, reproduction or behavior (data not shown). The smf-1
deletion eh5 resulted in a truncated SMF-1 protein containing only
the 6 first transmembrane domains and predicted to be devoid of
Mn transport activity (Fig. 1B). When exposed to Mn, smf-1(eh5)
mutants were twice as resistant as wild-type, with a LD50 = 94 mM
(Fig. 4). The smf-3 deletion ok1035 removes about 1,8kb in a region
encompassing exons 4 to 8. It leads to a loss of at least two of the
transmembrane domains 1 to 8, preventing the resulting truncated
protein from adopting its functional topology. In addition, the
likely loss of TMD6 impairs divalent metal (Me2+) transport as this
domain was proven essential for H+/Me2+ symporter activity [47].
In support of this assumption, the smf-3(ok1035) mutant displayed
the highest resistance to Mn exposure with a LD50 = 126 mM
(Fig. 4). The hyper-resistance to Mn exposure exhibited by both
smf-1(eh5) and smf-3(ok1035)mutants suggests that the Mn-induced
toxicity observed in wild type worms was at least, in part, mediated
through Mn uptake by the DMT1-like isoforms. A reasonable
explanation for this observation is that Mn uptake in these mutants
is impaired and that both SMF-3 and SMF-1 are required for
normal and optimal Mn uptake.
The deletion mutant smf-2(gk133) is hypersensitive to Mn treatment.
Concerning smf-2, the gk133 deletion affects the last hundred bases
of its promoter up to the third intron, which likely results in the
production of a defective protein, lacking the N-terminal sequence
up to the 5th TMD (Fig. 1B). Unlike smf-1(eh5) and smf-3(ok1035),
smf-2(gk133) mutant display a significant hypersensitivity to Mn
exposure with a LD50 = 26 mM (Fig. 4), suggesting a protective
role for SMF-2 against Mn toxicity.
smf-3(ok1035) mutants take up less Mn while smf-2(gk133) mutants take
up more. To confirm that the SMF proteins are involved in Mn
uptake, following acute Mn exposure, we collected wild-type, smf-
1(eh5), smf-2(gk133), and smf-3(ok1035) worms, and processed them
for Atomic Absorption Spectroscopy (AAS) analysis to measure
their Mn content. All four strains showed dose-dependent
increases in Mn content (Fig. 5A). smf-1(eh5) mutants accumulated
less Mn than wildtype animals, but the trend was not significant at
any of the tested doses. Strikingly, smf-2(gk133) accumulated
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Figure 1. The C. elegans genome encodes 3 SMF transporters orthologous to the plant, fungi and animal DMT protein family. (A)
Unrooted phylogenetic tree of a subset of eukaryotic members of the DMT family of transporters. C. elegans SMF proteins are more closely related to
the animal than to the fungus or plant orthologues. (B) Multiple alignment of animal DMT1 orthologues. The 12-transmembrane domain topology of
vertebrate DMT1 is conserved in C. elegans SMF proteins (black boxes), as well as the consensus transport sequence (red box). Dotted arrows indicate
regions of the proteins affected by the deletion alleles eh5, gk113, and ok1035 of smf-1, 2, and 3 respectively. Amino acids with similar biochemical
properties are highlighted with the same color. * represent residues conserved in all aligned sequences, : corresponds to highly conserved residues
and. to less conserved residues.
doi:10.1371/journal.pone.0007792.g001
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Figure 2. C. elegans SMF transporters rescue EGTA sensitivity of yeast DSmf1+DSmf-2mutant. S. cerevisiae double-mutant Smf1D+Smf-2D
is hypersensitive to exposure to the divalent cation chelator EGTA (red), when compared to wildtype (dotted black line). Transvections of C. elegans
smf-1 (blue), smf-2 (green) or smf-3 (orange) cDNA rescue the double-mutant hypersensitivity to EGTA.
doi:10.1371/journal.pone.0007792.g002
Figure 3. Mn exposure leads to severe osmoregulation defects and developmental delay. (A) Excretory canal in a control wild type L1
larva (solid white arrow heads). (B, C) Enlargement of the excretory canal in L1 larvae acutely exposed to 35 mM MnCl2, after 24 h (solid white
arrowheads) is associated with vacuolization (hollow arrowheads). Vacuoles are also observed in the sheath cells of the chemosensory organs (D) and
in the epidermis (E). (F) Control larva 24 h after 0 mM MnCl2 treatment. (G) Dying vacuolated (black arrowheads) larva 24 h after 35 mM MnCl2
exposure. (H) worms exposed to 35 mM MnCl2 (grey) are about 30% shorter than control animals (black). I, most larvae exposed to 35 mM MnCl2 are
still in L1 stage at 24 h post-treatment when control animals are L2. Error bars represent SEM, *** p,0.001, scale bars are 5 mm.
doi:10.1371/journal.pone.0007792.g003
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significantly more Mn at 35 mM (p,0.05), 100 mM (p,0.001)
and 150 mM (p,0.001) than any other strain, while smf-3(ok1035)
mutants accumulated significantly less Mn than the other strains,
both at 100 mM (p,0.001) and 150 mM (p,0.001).
smf-1(eh5) mutants exhibit a Mn-dependent decrease in Fe content while
smf-2(gk133) mutants are naturally depleted in Fe. In addition to Mn2+,
DMT1 can transport a wide range of metallic cations including
Zn2+, Pb2+, Cd2+, Ni2+, Co2+, and Fe2+ [67]. It has been shown in
rodents and cell cultures that Mn and Fe compete for transport via
DMT1 [66,68]. In particular, high intracellular Fe levels lead to
reduced Mn intake in rats [69]. To take into account a potential
influence of Fe levels on Mn content, we analyzed Fe levels in
parallel to Mn content. This analysis revealed that smf-2(gk133)
mutants have a significantly lower Fe content than the other
strains, which was not affected by Mn dose (Fig. 5B). Wildtype Fe
levels were not significantly impacted by 0 to 100 mM Mn
exposures, but showed an increase at 150 mM. Upon transient
Mn depletion, smf-1(eh5) and smf-3(ok1035) mutants displayed
higher Fe levels, but they underwent a gradual Fe depletion with
increasing Mn doses (Fig. 5B). smf-1(eh5) Fe content significantly
dropped below WT levels when exposed to 150 mM Mn,
suggesting a role for SMF-1 in Fe uptake at high Mn doses.
SMF-1 and SMF-3 expression partially overlaps in the main epithelia
while SMF-2 is restricted to minor epithelial tissues.
To understand better the differential roles of the smf genes in C.
elegans, we studied their expression pattern. We generated
transgenic strains expressing the green fluorescent protein (GFP)
under the control of smf-1, smf-2 or smf-3 promoters (smf-1::GFP,
smf-2::GFP, smf-3::GFP), as well as strains expressing GFP-tagged
SMF-1, SMF-2 and SMF-3 (SMF-1::GFP, SMF-2::GFP, SMF-
3::GFP). In all cases the GFP signal was detected from late
embryogenesis to adult stage, with generally higher expression
levels in young larvae (L1 stage). None of the transgenic strains
obtained showed any reproductive, developmental, behavioral or
morphological defects, or intracellular GFP aggregates, thus
establishing that the transgenes did not adversely affect the worms’
physiology and that their expression levels were likely within the
physiological range.
Both smf-1::GFP and SMF-1::GFP were prominently expressed
in the anterior and posterior intestine and associated gland cells
(Fig. 6A, 6B, 6C). A strong expression was observed in the anchor
cell (AC) during larval life and in the adult proximal uterus
resulting from the fusion of AC with uv1, uv2 and utse cells
(Fig. 6A, 6D, 6E). GFP signal was also consistently seen in the
adult spermatheca (Fig. 6F). Fainter expression was observed in
the major epidermis hyp7, in the pharyngeal muscles, and in a
subset of anterior sensory neurons, ring neurons, and posterior-
head neurons (Fig. 6A, 6G). SMF-3::GFP was mostly observed all
along the intestine, with a weaker expression in the most proximal
and distal regions (Fig. 6H, 6I). A weak epidermal expression in
hyp1-6, hyp7 and hyp8-12, and in head and tail neurons was also
seen (Fig. 6J, 6K, 6L, 6M). In contrast to the broad SMF-1::GFP
and SMF-3::GFP expression patterns, SMF-2::GFP was mostly
restricted to the mc1, mc2, mc3 epithelial cells of the pharynx and
the pharyngeal-intestinal valve cells vpi1-6, displaying an anterior-
posterior expression gradient (Fig. 6N, 6O). SMF-2 was also
observed in the gonad sheath cells at the adult stage (Fig. 6P, 6Q).
SMF-1 and SMF-3 are apically localized while SMF-2 is mainly
cytoplasmic. The full-length SMF-1::GFP and SMF-3::GFP allowed
us to observe the intracellular localization of SMF-1 and SMF-3.
In vertebrates, the DMT1 isoforms are mostly localized at the
apical side in intestinal, rectal and kidney epithelial cells [66]. In
agreement, SMF-1::GFP and SMF-3::GFP were localized at the
apical plasma membrane in all epithelia in which they were
expressed (Fig. 7A, 7B). Conversely, SMF-2::GFP was associated
with intracellular cytoplasmic compartments and to a lesser extent
to the apical membrane of the mc epithelial cells (Fig. 7C).
Variation in SMF protein levels/localization upon Mn exposure. Studies
in vertebrates and yeast showed that DMT1 and DMT1-like
isoforms are differentially regulated by metals, such as Fe and Mn
[66]. In particular, modulation of expression and protein levels by
Fe has been extensively studied [66]. In vertebrates, the DMT1
gene encodes two to four isoforms, defining two functional types
which depend upon the presence of an Iron-Responsive Element
(IRE) in their 39UTR (+IRE isoform) or its absence (-IRE isoform)
[70]. A consensus sequence for this IRE has been identified in
Figure 4. Dose-response lethality curves reveal a differential sensitivity to Mn exposure for smf mutants compared to wild type
worms. Upon 30 min exposure to MnCl2 as L1 larvae the lethal concentration 50 (LD50) at which half of the worms were dead at 24 h, was 47 mM for
wildtype worms (black, N = 12), 93 mM for smf-1 mutants (blue, N= 6), 26 mM for smf-2 mutants (green, N= 7), and 126 mM for smf-3 mutants
(orange, N= 5). Error bars represent SEM, *** p,0.001.
doi:10.1371/journal.pone.0007792.g004
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several proteins involved in Fe metabolism and regulation [71].
Yeast studies also showed differential regulation of Smf genes upon
Mn and Fe exposure or depletion [55]. More specifically, in Mn-
replete conditions, Smf1p and Smf2p are targeted to the vacuole
for degradation, but they accumulate at the plasma membrane
and in intracellular vesicles uponMn depletion [56,72,73]. Unlike
Smf1p and Smf2p, which are regulated by Mn at a post-
translational level, Sm3p is regulated by Fe at a transcriptional
level [56]. Given the impact of metal cation levels (Fe and Mn) on
DMT1 isoform expression and localization in both vertebrate and
fungus models, we addressed the possibility that C. elegans SMF
activity may also change with environmental Mn concentration.
We used C. elegans strains transgenic for the SMF::GFP reporters
to follow DMT1-like protein expression and localization changes
Figure 5. Variations in Mn and Fe content in smf mutant worms upon Mn exposure. (A) WT and smf mutants take up Mn in a dose-
dependent manner. smf-2(gk133) (green) takes up significantly more Mn than WT (black) and other mutant worms following exposure to 35
(# p,0.05), 100 (## p,0.001) and 150 mM (### p,0.001) MnCl2. smf-3(ok1035) (orange) mutants take up significantly less Mn than other worms
at 100 (## p,0.01) and 150 mM (### p,0.001). (B) Fe content varies differentially in smfmutants and WT upon Mn exposure. smf-2(gk133) (green)
display significantly lower Fe levels (# p,0.05), while smf-1(eh5) and smf-3(ok1035) mutants show higher Fe levels (# p,0.05) than WT in absence of
Mn treatment (0 mM), and at very low Mn concentration for smf-1(eh5) (0.001 mM). Error bars represent SEM. While # designate significant
differences between genetic backgrounds exposed to the same manganese dose, * indicate significant differences between exposure doses within
the same C. elegans strain: #/* p,0.05. ##/** p,0.01, ###/*** p,0.001.
doi:10.1371/journal.pone.0007792.g005
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upon Mn exposure. We performed the same L1 acute treatment
protocol as for our Mn toxicity and Mn content measurements,
and collected worms at 1, 5 or 30 hours post-treatments for image
analysis. SMF-1::GFP and SMF-2::GFP expressing worms did not
show any obvious changes in either expression levels or
intracellular localization. However, 1 hour post-treatment,
SMF-3::GFP was translocated to apical vesicular compartments
in the L1 intestine (Fig. 8A, 8B); at 5 hours the intestinal GFP
signal was considerably reduced; it was not solely restricted to the
apical plasma membrane, showing also cytoplasmic expression
(Fig. 8C). This phenomenon was reversible, since at 30 hours
post-exposure, both the expression levels and the subcellular
localization of SMF-3::GFP returned to normal (Fig. 8D). These
observations are supported by quantifications of SMF-3::GFP
fluorescence at 5 and 30 hours, showing a significant decrease of
SMF-3::GFP levels at 5 hours, but not at 30 hours post-treatment
(Fig. 8E). This result suggests that SMF-3 function is regulated by
Mn levels and further supports a major role for SMF-3 in Mn
uptake.
Variation in smf gene expression by RT-PCR. Given the fact that C.
elegans expresses DMT1-like isoforms with partially overlapping
expression patterns, we examined if they displayed some
functional redundancy and if their relative expression levels were
dependent on each other and on metal levels. We also wondered
whether SMF-3::GFP down-regulation upon Mn exposure could
be explained by transcriptional inhibition. To address these issues
we conducted quantitative real-time reverse-PCR assays (QRT-
PCR) on wild-type, smf-1(eh5), smf-2(gk133), and smf-3(ok1035)
worms acutely exposed to 0, 1, 10, 100 mM of MnCl2. Both
primers sets used to monitor smf gene transcriptional levels showed
that smf-1 and smf-3 were up-regulated at 0.1 mM of Mn and
down-regulated at 10 and 100 mM Mn in WT and smf mutants,
but not in smf-2(gk133) (Fig. 9A, 9B, 9C). As expected, smf-1
expression was undetectable in smf-1(eh5), since the smf-1 primers
were chosen within the deleted region in smf-1(eh5) (Fig. 9A). In
smf-1(eh5) and smf-3(ok1035) mutants, smf-2 was also up-regulated
at 0.1 mM of Mn and down-regulated at 10 and 100 mM Mn,
while in WT, smf-2 expression was not affected by any of the Mn
levels (Fig. 9B).
Noticeably, smf-2 was strongly overexpressed in smf-1(eh5)
(Fig. 9B). In smf-3(ok1035), all smf genes were found overexpressed
compared to WT, especially smf-3 (Fig. 9C), implying that a
functional SMF-3 is required to maintain normally low smf gene
expression. Lastly, smf gene expression was not influenced by Mn
exposure in the smf-2(gk133) genetic background (Fig. 9A, 9B, 9C).
This observation supports a role for SMF-2 in smf gene regulation
upon changes in environmental Mn status.
Discussion
We identified three new functional members of the DMT1
family in C. elegans. All three rescued the yeast DSMF1+2 EGTA
sensitivity, and revealed important for metal homeostasis in the
worm, with very little functional overlap. SMF-1 and SMF-3 were
Figure 6. Expression pattern analysis of C. elegans smf genes. A,
SMF-1::GFP strongly localizes to the anterior and posterior intestine
(solid white arrowheads), to the anchor cell (hollow arrowhead) and to
head neurons (white arrows). smf-1::GFP and SMF-1::GFP reveal
expression of smf-1 gene in rectal gland cells (B,C, black asterisks), in
the uterus (uv1, uv2, utse syncytium, D,E, solid white asterisks) as well as
in the adult spermatheca (F) and the L1 hyp7 epidermis (G, white
arrowheads). Dotted lines outline the cuticle of the worm. Hollow
asterisks indicate position of fertilized embryos. Hollow arrowheads
indicate position of the vulva. smf-3 is mainly expressed in the intestine
as revealed by smf-3::GFP (H) and SMF-3::GFP (I), in the major epidermis
hyp7 (J, dotted line) and head epidermis hyp1-6 (K, dotted line), and in
head (L) and tail neurons (M). An antero-posterior gradient of smf-2
expression is noticeable in the 9 marginal epithelial cells of the pharynx
(mc1, mc2, mc3) and the 6 vpi cells of the pharyngeo-intestinal valve (N
and O). Fainter expression is consistently observed in the proximal
gonad (P, Q). Scale bars are 5 mm.
doi:10.1371/journal.pone.0007792.g006
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broadly expressed in C. elegans epithelia; they were required for
Mn uptake and toxicity, and exhibited the classical apical
localization of DMT1. Conversely, SMF-2 expression was
essentially restricted to specialized pharyngeal cells, where it was
predominantly cytoplasmic, and to endow partial protection
against Mn-induced toxicity. SMF-1 and SMF-2 were both
required for normal Fe intake, SMF-2 being necessary for Mn-
dependent Fe content regulation. Mn exposure revealed influential
on transcriptional regulation of the three smf genes, but only
affected the post-translational regulation of SMF-3. Our results
Figure 7. Subcellular localization of SMF::GFP reporters. SMF-1::GFP mostly localizes to the apical plasma membrane of the intestine and sub-
apical compartments (A, D, dotted line in A underlines the basolateral membrane of the intestine, dotted lines in D delimit its apical plasma
membrane). SMF-2::GFP is seen in cytoplasmic organelles in mc and vpi cells (E, cell plasma membranes are marked by a dotted line, N indicate the
position of the nuclei). SMF-3::GFP is mainly restricted to the apical plasma membrane of the intestine and apical vesicular organelles (C, F, dotted line
in C underlines the basolateral membrane of the intestine, dotted lines in D delimit its apical plasma membrane). Scale bars are 5 mm.
doi:10.1371/journal.pone.0007792.g007
Figure 8. SMF-3::GFP is down-regulated upon Mn exposure. SMF-3::GFP signal is strongly detected at the apical plasma membrane prior Mn
treatment (A). After 1 hour of exposure to 35 mM MnCl2, SMF-3-GFP localizes to sub-apical vesicular compartments (B). C, SMF-3::GFP signal is
strongly decreased at 5 hours post-treatment. After a day of recovery, SMF-3::GFP expression returns to control levels and SMF-3::GFP relocates to the
apical plasma membrane (D). Scale bars are 5 mm. (E) quantification of apical plasma-membrane SMF-3::GFP in the whole intestine after 5 and 30 h of
exposure in control and treated animals. While # designate significant differences between genetic backgrounds exposed to the same manganese
dose, * indicate significant differences between exposure doses within the same C. elegans strain: #/* p,0.05. ##/** p,0.01, ###/p,0.001.
doi:10.1371/journal.pone.0007792.g008
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Figure 9. Genotype and Mn exposure influence on smf gene expression. Both independent primer sets corresponding to the 39 end of the
cDNA and used to assess smf gene expression (set A bright colors, and set B faded colors) give consistent results (A, B, C). smf-1 and smf-3 mRNA
levels display similar variations, increasing at low Mn exposure (0.1 mM) and decreasing upon high Mn concentrations (10 mM and 100 mM) in WT,
smf-1 and smf-3 mutants (A, C, black, blue, orange). smf-2 mRNA levels follow the same tendency in smf-1 and smf-3 mutants but are not affected by
Mn exposure in WT (B). Independent of Mn exposure, smf-1(eh5) mutant is characterized by a strong up-regulation of smf-2 expression (B, blue).
Compared to other genotypes, smf expression in smf-2(gk133) does not appear to correlate with Mn exposure (A, B, C, green). The smf-3(ok1035)
mutant exhibits higher smf gene expression levels regardless of Mn exposure dose (A, B, C, orange). While # designate significant differences
between genetic backgrounds exposed to the same manganese dose, * indicate significant differences between exposure doses within the same C.
elegans strain: #/* p,0.05. ##/** p,0.01, ###/p,0.001. Displayed significance levels between treatments reflect the weakest significance score
obtained between both primer sets.
doi:10.1371/journal.pone.0007792.g009
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unravel a complex metal-regulation system involving 3 distinct
DMTs coordinately regulated by metal levels, and bear interesting
implications on the modulation of the vertebrate DMT activities
carried out by NRAMP1 and DMT1 isoforms.
SMF-3 regulates and is specifically regulated by Mn. In addition to
expression and localization data, Mn content measurement and
dose-response lethality curves in smf mutants clearly indicate that
SMF-3 is a major Mn transporter in the worm, which is required
for Mn-induced toxicity. smf-3(ok1035) is the mutant most resistant
to acute Mn exposure (Fig. 4). SMF-3 is expressed in the epidermis
and located all along the intestine, where most Mn absorption
likely occurs (Fig. 6). SMF-3 sub-cellular localization is apical,
consistent with a role in Mn uptake (Fig. 7). smf-3(ok1035) is the
only mutant that displays a significant decrease in Mn content
upon MnCl2 treatment (Fig. 5), implying that SMF-1 or SMF-2
cannot compensate for SMF-3 depletion. Moreover, SMF-3 levels
and apical localization are strongly decreased 5 hours after toxic
Mn exposure and are restored after a 24 hour recovery period
(Fig. 8). Finally, QRT-PCR revealed a decrease in smf-3 mRNA
levels upon Mn exposure at 10 and 100 mM (Fig. 9). These
observations support the notion that smf-3 is down-regulated both
transcriptionally and post-translationally upon Mn exposure,
which limits toxic accumulation of Mn in the worm. After a day
of recovery allowing for the excretion of Mn accumulated upon
previous exposure, SMF-3 levels return back to normal levels,
permitting nutritional divalent cation uptake. Our experiments
support a regulation of SMF-3 levels at the post-translational level,
by relocating and degrading SMF-3. The translocation of SMF-3
likely to endosomal compartments in response to excessive Mn
exposure can be related to the vacuolar targeting of Smf1p and
Smf2p in Mn-replete conditions in yeast [56,73,74]. In porcine
kidney cells, (-IRE)-DMT1 isoforms have been shown to be more
rapidly and efficiently internalized upon metal exposure when
compared to (+IRE)-DMT1 isoforms [39]. Although we did not
find any typical IRE sequence in any of the three smf 39UTR
sequences (data not shown), we observed a drastic internalization
of SMF-3 upon Mn treatment, but not of SMF-1 or SMF-2.
Additionally, DMT1 has the highest affinity for Mn2+ [67] and
SMF-3 is the C. elegans orthologue that is responsible for most Mn
uptake. Hence, in C. elegans, SMF-3 may be the functional
counterpart of the vertebrate -IRE forms of DMT1.
An atypical role for SMF-2 in Mn homeostasis. smf-2 is located
downstream of smf-1 on the X chromosome. Due to the absence of
any splice acceptor site in the smf-2 sequence and based on our
GFP-reporter analysis, it is unlikely that smf-1 and smf-2 belong to
the same operon. Indeed, both exhibited very distinct expression
patterns (Fig. 6) and mutations in smf-1 or smf-2 have opposite
effects on Mn sensitivity (Fig. 2). The high degree of conservation
between both genes suggests that they result from a duplication
that happened early in the Caenorhabditis lineage, since it is also
found on the C. briggsae and C. remanei X chromosomes (http://dev.
wormbase.org/db/seq/gbrowse_syn/pecan/?search_src= elegans;
name= chrX%3A6716267..6721098). smf-2(gk133) mutants exhib-
ited hypersensitivity to Mn exposure and a higher Mn content than
wild type worms (Fig. 2, 5), indicating that SMF-2 partially protects
against Mn exposure, which may not be solely explained by a role in
Mn uptake. The intestinal expression of SMF-1 and SMF-3 from
late embryogenesis to adulthood strongly supports their involvement
in metal uptake, while SMF-2 expression and subcellular localization
in the pharyngeal epithelial cells is intriguing, since these cells are not
known to be involved in nutrient or toxicant uptake (http://www.
wormatlas.org/handbook/alimentary/alimentary1.htm).
SMF-2 may rather be involved in the regulation of Mn toxicity,
either by allowing its excretion, its sequestration, or the
modulation of Mn uptake via the other DMT1-like isoforms, or
a combination of the above. Because of the structural and
functional similarities between SMF-3, SMF-1 and SMF-2, we
favor the idea that pharyngeal SMF-2 takes up metallic cations,
allowing for the overall regulation of Mn content. Several
hypotheses can be formulated. First, SMF-2 could work as a
sensor of environmental Mn levels, and a downstream signaling
pathway would either impact Mn uptake via SMF-3 and SMF-1 or
Mn excretion via as of yet uncharacterized transporters. The
anterior-posterior gradient of SMF-2 expression in the pharynx
would provide a differential mechanism to accurately estimate
metal concentrations. Second, SMF-2-driven inhibition of Mn
uptake could involve modulation of the pharyngeal pumping. The
marginal cells of the pharynx, which express SMF-2, are
electrically coupled to the pharyngeal muscles by gap-junctions
[75]. In mammalian cells, high Mn concentrations have been
shown to impact cardiomyocyte contractility by inhibiting the
Ca2+-ATPase [76,77]. Considering the structural and functional
similarities between the C. elegans pharynx and the vertebrate heart
[78], Mn uptake via SMF-2 in marginal cells might impact
pharyngeal muscle activity. Decrease in pharyngeal pumping
would result in reduced nutrient and Mn intake. This could also
account for the slow growth of Mn-treated animals. Third, our Fe
content analysis suggests that SMF-2 is an important Fe
transporter. The lack of SMF-2 leads to lower Fe levels in the
smf-2(gk133) worms (Fig. 5B), which would allow for increased Mn
uptake by SMF-3 or SMF-1 (Fig. 5A). Moreover, Fe content is
high at low Mn exposure, and drops at high Mn exposure in smf-
1(eh5) and smf-3(ok1035) mutants, while it is constant in smf-
2(gk133) mutants (Fig. 5B). The smf gene expression also follows
this trend. It suggests that SMF-2 is required for Mn-dependent
variations in Fe content and smf gene expression. SMF-2 is active
in a different cell type as SMF-1 and SMF-3 (Fig. 4), and those
cells are connected through gap-junctions. To reconcile these data,
we propose that SMF-2-dependent Fe-uptake is inhibited at high
Mn doses, leading to a Fe-depletion in the pharynx and a reversed
Fe gradient across the animal. In turn this Fe imbalance, together
with increased Mn content would lead to the down-regulation of
smf genes in a SMF-2-dependent manner (Fig. 10B).
Based on SMF-2::GFP subcellular localization (Fig. 7), which
appears to be in puncta in the cytoplasm, but not in the nucleus,
SMF-2 could be present in most membranous intracellular
organelles of the endo-lysosomal pathway. Its activity could be
increased by the V-ATPase-driven acidification of those compart-
ments, similarly to DMT1 in endosomes and NRAMP1 in
phagosomes [33], leading to metal transport to the cytosol. On the
one hand, generation of double-transgenic C. elegans strains to
conduct colocalization studies with lyzosomal (LAMP-1 and
LAMP-2) and endosomal (RAB-5, RAB-7) markers would be
beneficial in determining if the puncta seen in Fig. 7 correspond to
endo-lyzosomal compartments. On the other hand, colocalization
with an essential V-ATPase subunit, such as VHA-8 [89], and
observation of orange acridine (pH-sensitive vital dye) staining in
SMF-2-positive puncta and measurement of C. elegans Fe content
upon variation in environmental pH, could be used to study the
pH-dependency of SMF-2 function.
SMF-1: minor in Mn physiology, major in Fe homeostasis? Though
expression pattern, sub-cellular localization and mutant analysis
might suggest an important role for SMF-1 in Mn2+ uptake, Mn
content measurements failed to show a significant difference
between wild type and smf-1(eh5) mutant worms. Thus, a
difference in Mn uptake may not account for their resistance to
Mn exposure. Several hypotheses may be advanced to explain this
apparent discrepancy. First, SMF-1 may mediate Mn toxicity
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Figure 10. Working model for Mn and Fe uptake by SMF transporters in C. elegans. A: Regulation of Mn, Fe contents and SMF transporters
upon low Mn exposure (0.001 mM to 3 mM), which is believed to be beneficial for the worm physiology [92]. B: Regulation of Mn, Fe contents and
SMF transporters upon high Mn exposure (50 mM to 150 mM), which was shown to be toxic (Fig. 3, 4). We propose that SMF-3* is the main
transporter responsible for Mn uptake (A), and that it is degraded upon exposure to high Mn concentrations (B). Since high Fe content limit Mn
uptake, SMF-3 may be inhibited by intracellular Fe (A). SMF-1 would be involved in Mn uptake to a lesser extent, and together with SMF-2*, would be
responsible for Fe uptake. Upon Low Mn exposure SMF-2 would be mostly required for Fe uptake (A), whereas upon high Mn exposure, SMF-2 would
be inhibited and SMF-1 would partially compensate for Fe uptake (B). In the case of SMF-2 and SMF-1, metal uptake could essentially take place in
acidified endosomal compartments, as SMF-2 is mainly cytoplasmic and SMF-1 is detected in sub-apical compartments. Gap-junction
communications between pharyngeal epithelia, vpi cells and intestinal cells permit Mn2+ and Fe2+ to diffuse distant from their site of uptake,
allowing metal-dependent regulation of smf mRNA stability or transcription. A prediction of our model is that the Fe gradient established by SMF-2
activity would be reversed upon high Mn exposure (B), and could constitute the signal for smf expression regulation. Since basal smf mRNA levels
depend on the integrity of each smf genomic sequence (Fig. 9), transcriptions of smf genes are assumed to be interdependent, maybe because they
require a common transcription factor. * SMF-2 might transport Mn and SMF-3 might transport Fe, but these possibilities are not explored in this
model. The size of the text reflects the concentration of the species.
doi:10.1371/journal.pone.0007792.g010
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subsequent to Mn uptake at the apical membrane of the intestine,
transporting Mn from endocytic compartments to the cytosol. In
absence of SMF-1, endocytic Mn content would remain the same,
but Mn would not be transported across the membrane to reach
the cytosol and trigger toxicity (Fig. 10). The presence of SMF-1 in
intracellular vesicular organelles supports this idea (Fig. 7). When
located at the apical plasma membrane, SMF-1 would then be
largely inactive; being activated upon acidification of the endocytic
vesicles by the vacuolar-ATPase [33,48,79]. Second, SMF-19s
contribution to Mn uptake may be minor compared to SMF-3 and
Mn content measurements would not be able to reflect the
relatively limited, yet physiologically significant variations in Mn
content. This alternative explanation is logical within the context
of the DMT family, in which different isoforms have been shown
to transport distinct cations with variable efficiencies. Hence, the
vertebrate NRAMP1 is a critical Fe transporter in macrophages
[80,81,82], and has a poor affinity for Mn compared to DMT1
[67]. SMF-1 may thus be the counterpart of NRAMP1 in the
worm, being predominantly required for Fe uptake. Additionally,
smf-1(eh5) is the only mutant which showed a significant Mn-
dependent depletion of Fe content, despite the overexpression of
smf-2 in this context. It indicates that SMF-1 is required to take up
or conserve Fe at high Mn concentrations, and may be responsible
for Fe homeostasis (Fig. 10). Third, the QRT-PCR experiments
revealed that the smf-1(eh5) mutant exhibits a higher smf-2
expression level than wildtype, smf-2(gk133) and smf-3(ok1035)
worms. If as mentioned previously SMF-2 is protective against Mn
toxicity, the resistant phenotype of the smf-1(eh5) mutant may
reflect the overexpression of SMF-2. In this case, SMF-1 would
not necessarily be involved in Mn transport. Fourth, the previous
hypotheses are not mutually exclusive. Lastly, SMF-1 is able to
rescue EGTA sensitivity in yeast beyond WT level (Fig. 2). This
better rescue could be due to a higher transgene copy number or a
better stability of the SMF-1 product in the yeast, resulting in
higher SMF-1 levels and a hypermorphic phenotype. However, it
could also indicate that this transporter has a broader range of
substrates than SMF-2 and SMF-3 and may be functionally closer
to a canonical DMT.
New insights for the study of the eukaryotic family of DMT1-related
transporters. Our analysis of the C. elegans DMTs reveals that they
are closely related structurally and functionally to their vertebrate
orthologues. SMF-1 and SMF-3 are apically localized in epidermal
and intestinal cells, consistent with observations about DMT1
distribution and sub-cellular localization in vertebrates [47,85,86].
Moreover, DMT1 proteins transport divalent metallic cations via
coupling with the proton gradient [47] in part generated by the
vacuolar-ATPase apically localized both in vertebrates and in C.
elegans epithelia [66,89,90]. Interestingly, the three C. elegans
isoforms display distinct expression levels and contribute differen-
tially to Mn and Fe physiology, similarly to the +IRE, -IRE forms
of DMT1 and NRAMP1 in vertebrates. The fact that SMF-2
antagonizes SMF-3 could be connected to the suspected antiporter
activity of NRAMP1 relatively to the symporter activity of DMT1.
NRAMP1 was proposed to be extruding metals against the proton
gradient [91]. This activity would rely on specific residues located
before the transmembrane domains (TMD) 9 and 12, which differ
between NRAMP1 and DMT1. In particular, in mammals,
NRAMP1 exhibits a basic residue K389 instead of a polar residue
N403 for DMT1, at the end of the CTS. Interestingly, our
multiple-alignment reveals that all other DMT1 orthologues
including Malvolio, SMF-3 as well as yeast Smf1p, Smf2p and
Smf3p display a polar residue (N or Q) at this position, while SMF-
1 and SMF-2 show a basic residue (R or K) similarly to NRAMP1
(Fig. 1). SMF-2 also seemed to limit Mn accumulation. However,
unlike NRAMP1, SMF-1 and SMF-2 efficiently rescue the yeast
DSMF1+2 EGTA sensitivity. Moreover, their expression in the
proximal digestive system argues against an antiporter activity that
would result in metal extrusion. Therefore, it would be very
interesting to test the ability of SMF-1 and SMF-2 to rescue the
heavy metal ion stress in DBSD2/DRER1 yeast mutants.
Ultimately the symporter or antiporter activity of DMTs may
depend on the metal ions and their concentrations on both sides of
the membrane. Environmental, cytosolic and organelle metal
concentrations in yeast, oocytes, macrophages or distinct C. elegans
cell types may vary enough for DMTs to function differently
depending on the context. Another point is that the specific
expression patterns of SMF-1, SMF-2 and SMF-3 remained the
same through the worm’s post-embryonic life, implying that the
cell-specific expression levels of smf genes are embryonically
determined, further variations resulting from changes in metal
exposure and physiology.
Analysis of our results allows us to propose a working model for
Mn and Fe uptake regulation in C. elegans (Fig. 10). We favor the
notion that metal ion gradients play the key role in the regulation
of expression, sub-cellular localization and activity of DMTs in C.
elegans. To further test this idea, fluorescent ferrochromes could be
used to visualize in vivo the Fe gradient upon various Mn
exposures. To yield further information on the metal-transport
abilities of the various DMTs from worm to human, one could
perform a systematical comparative analysis of DMT family
member biochemical properties in yeast using complementation
rescue of DBSD2/DRER1 and DSMF1+2mutants, coupled to an in
vivo study using metal-exposed transgenic C. elegans expressing
tissue-specific chimerical DMT transgenes. Such a dual approach
should help solve the paradox concerning the antiporter activity of
NRAMP1 orthologues, and the effect of metal gradients on DMT
activity.
To dissect out the relative contributions of each smf gene in
metal physiology in C. elegans, the generation of double or triple smf
mutants would also be of great interest. However generation of the
smf-1;smf-2 double mutant and the triple mutant smf-1;smf-2;smf-3
would require a new deletion mutant in which both smf-1 and smf-
2 expressions are lost, since the short genetic distance between
both genes would make recombination events between smf-1(eh5)
and smf-2(gk133) very unlikely. In addition, considering that smf-2
is strongly up-regulated in smf-1(eh5) (Fig. 9), it is possible that the
eh5 deletion, by bringing smf-1 promoting or enhancing sequences
closer to the smf-2 gene, affects its natural expression. This
potential issue should be carefully considered before further usage
of smf-1(eh5) to generate double-mutants. Combining RNAi and
single mutants could be another way to address the redundancy
issue, with the limitation that RNAi may not be fully penetrant or
specific enough to affect single isoforms.
Relevance of our C. elegans model to study Mn toxicity and related diseases.
Mn exposure has long been suspected to be responsible for IPD
cases. The commonalities between manganism and PD suggest that
both pathologies, at least in part, rely on shared genetic networks
and molecular mechanisms. Due to the increasing incidence of PD,
notably in most populous countries [23], there is growing interest in
identifying contributing genetic and environmental factors. In this
context, development of amenable genetic models to study gene-
environment interactions is essential. Our work corroborates the
utility of C. elegans as an appropriate complementary whole-animal
model to decipher molecular mechanisms and genetic predisposi-
tion to metal induced toxicity. First, we showed that C. elegans takes
up Mn readily and is sensitive to Mn exposure, exhibiting
developmental delay, excretory cell and osmoregulatory defects
which can be related to kidney and bladder defects observed in
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rodents [83,84] and man [44]. The high Mn concentrations used in
our study (when compared to cell-culture studies in which the LD50
approximates 1 mM for 24 h exposures) likely reflect three
characteristics of the model. C. elegans is sheathed with a cuticle
impermeable to ions and only few orifices would physically allow
metal ion uptake, namely the mouth, the rectum, the pore cell of the
excretory system and the chemosensory organs. In support of this,
the Mn content measured by atomic absorption spetrophotometry
(AAS) in wild-type worms treated at the LD50 (47 mM) corre-
sponded to an effective dose of 12.5 mM. Another point to consider
is that the worms in the present study were acutely treated (30 min)
in contrast to most cell culture studies that involve more protracted
exposures (.24 h). It is also likely that the worm, naturally living in
soil, where ion concentrations fluctuate greatly and rapidly, may be
physiologically more robust than mammalian cells. Second, our
functional analysis of the SMF transporters in the yeast (Fig. 2)
together with the metal content measurements in wild type and smf
mutant worms (Fig. 5A), show that the three C. elegans DMTs are
involved in metal uptake regulation. Third, two of these
transporters, SMF-1 and SMF-3 are mostly expressed in the
intestine, a portal for Mn and Fe uptake both in worms and
vertebrates. SMF-1 and SMF-3 are also apically localized in
epidermal and intestinal cells, consistent with observations about
DMT1 distribution and sub-cellular localization in vertebrates
[47,85,86]. Fourth, several facts inherent to the regulation of DMTs
by Mn or Fe and vice-versa previously described in mammalian
models also hold true in C. elegans. For example, we showed that low
Mn exposures (0.1 mM) tend to increase and high concentrations
(100 mM) to decrease smf gene expression (Fig. 9). SMF-2 was
required in this regulation process as Mn concentration-dependent
effects are not observed in the smf-2(gk133) mutant (Fig. 5, 9). Fifth,
Fe and Mn tissue levels are interdependent and depend on
environmental concentrations. In the smf-2(gk133) mutant, low Fe
content is associated with an increased ability to take up Mn. In smf-
1(eh5), Fe content decreases with increasing Mn exposure (Fig. 5).
Last, we found that SMF-3 N-terminal sequence contains a putative
Mitochondrial Targeting Sequence (MTS, probability 93.66%
given by MitoProt, http://ihg2.helmholtz-muenchen.de/ihg/
mitoprot.html): MPRVHRQSRWNSVSFSGFFLQISGIKPRF.
Our analysis of SMF-3::GFP sub-cellular localization did not
reveal any epithelial mitochondrial targeting in vivo. However, it
could happen in tissues that were not investigated in this study
such as neurons, or in situations that were not covered by our
experimental conditions. If it was confirmed, a mitochondrial
targeting of DMT1 orthologues would mean that their activity
could directly impact mitochondrial function and potentially
apoptosis, in particular in neurodegenerative processes [87,88].
Taken together, our data suggest that Mn uptake and toxicity
mechanisms involving DMTs are conserved from nematodes to
man. Because other genetically amenable invertebrates such as D.
melanogatser only express one DMT (Malvolio, Mvl), and given the
large panel of currently available techniques on the nematode
(toxicology, molecular biology, forward and reverse genetics,
confocal and electron-microscopy, biochemistry), C. elegans pro-
vides a convenient in vivo platform to further investigate metal
toxicity and related neurodegenerative disorders in which DMT1-
related transporters are suspected to play an important role
[87,88].
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